午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

1,4-Oxazepine-3-carboxylic acid, hexahydro-

1,4-Oxazepine-3-carboxylic acid, hexahydro- Struktur
1262407-75-9
CAS-Nr.
1262407-75-9
Englisch Name:
1,4-Oxazepine-3-carboxylic acid, hexahydro-
Synonyma:
1,4-oxazepane-3-carboxylic acid;1,4-Oxazepine-3-carboxylic acid, hexahydro-
CBNumber:
CB48312002
Summenformel:
C6H11NO3
Molgewicht:
145.16
MOL-Datei:
1262407-75-9.mol

1,4-Oxazepine-3-carboxylic acid, hexahydro- Eigenschaften

Siedepunkt:
308.7±42.0 °C(Predicted)
Dichte
1.175±0.06 g/cm3(Predicted)
pka
2.11±0.20(Predicted)

Sicherheit

1,4-Oxazepine-3-carboxylic acid, hexahydro- Chemische Eigenschaften,Einsatz,Produktion Methoden

1,4-Oxazepine-3-carboxylic acid, hexahydro- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1,4-Oxazepine-3-carboxylic acid, hexahydro- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49734 58
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323658 +86-18168183658
 sales1@artkmedchem.com China 39002 58
ForeChem (Nantong) Technology Co.,Ltd. 513-85982855 18921614129
 sales@xianxingpharm.com China 3068 61
Bide Pharmatech Ltd. 400-164-7117 13681763483
 product02@bidepharm.com China 42446 60
Birdo (Shanghai) Medical Technology Co., Ltd. 021-58099077-8041 18601625411
 sales@birdotech.com China 10000 58
Taizhou Nanfeng Pharmaceutical Research Institute nanfengdrug@163.com; 18616377689
 nanfengdrug@163.com China 20009 58
Shanghai Haohong Pharmaceutical Co., Ltd. 400-8210725 4008210725
 malulu@leyan.com China 54999 58
Shanghai Yanbang Pharmaceutical Technology Co., Ltd 15618536883
 1228181347@qq.com China 7951 58
Aikon International Limited 025-58851090 13408877820
 2850281427@qq.com China 10000 58
  • 1,4-Oxazepine-3-carboxylic acid, hexahydro-
  • 1,4-oxazepane-3-carboxylic acid
  • 1262407-75-9
Copyright 2019 ? ChemicalBook. All rights reserved